Page last updated: 2024-08-21

cepharanthine and pf 00299804

cepharanthine has been researched along with pf 00299804 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, WX; Chen, X; Dai, XY; Guo, X; Lu, JH; Lu, JJ; Tang, ZH; Zhu, H	1

Other Studies

1 other study(ies) available for cepharanthine and pf 00299804

Article	Year
Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer. Cancer letters, 2018, 01-01, Volume: 412 Topics: Animals; Antineoplastic Agents; Autophagy; Benzylisoquinolines; Carcinoma, Non-Small-Cell Lung; Cathepsins; Cell Line, Tumor; ErbB Receptors; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Mice; Quinazolinones	2018

Article

Year

Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer.

Cancer letters, 2018, 01-01, Volume: 412

Topics: Animals; Antineoplastic Agents; Autophagy; Benzylisoquinolines; Carcinoma, Non-Small-Cell Lung; Cathepsins; Cell Line, Tumor; ErbB Receptors; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Mice; Quinazolinones

2018